Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding

Scandinavian Journal of Work, Environment and Health

Volumn 36, Issue 5, 2010, Pages 413-421

  Fei, Chunyuan ^a   McLaughlin, Joseph K ^b,c   Lipworth, Loren ^b,c   Olsen, Jørn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Infant; Maternal blood; Perfluorinated chemicals; PFC

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

BREASTFEEDING; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); INFANT FEEDING; LACTATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC POLLUTANT; PREGNANCY; RODENT; TELEPHONE NETWORK; WOMENS HEALTH;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BREAST FEEDING; CORRELATION ANALYSIS; EXPOSURE; FEMALE; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; INTERVIEW; LACTATION; MATERNAL BLOOD; POSTNATAL DEVELOPMENT; PREGNANT WOMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TELEPHONE; WEANING;

MUS;

EID: 77956243542     PISSN: 03553140     EISSN: 1795990X     Source Type: Journal    
DOI: 10.5271/sjweh.2908     Document Type: Article

References (39)

1. Poulsen PB, Jensen AA, Wallström E. More environmentally friendly alternatives to PFOS-compounds and PFOA. Copenhagen (Denmark): Danish Environmental Protection Agency; 2005.
2. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99(2):366-94. (Pubitemid 351753056)
3. Sibinski LJ. Two-year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 (perfluorooctane ammonium carboxylate) in rats. Report prepared for 3M, St. Paul, Minnesota by Riker Laboratories Inc. Study No. 0281CR0012; 8EHQ-1087-0394, October 16, 1987.
4. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci. 2007;96(1):133-44.
5. Yang C, Tan YS, Harkema JR, Haslam SZ. Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod Toxicol. 2009;27(3-4):299-306.
6. White SS, Kato K, Jia LT, Basden BJ, Calafat AM, Hines EP et al. Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod Toxicol. 2009;27(3-4):289-98.
7. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci. 2003;74(2):382-92.
8. Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci. 2006;90(2):510-8.
9. Olsen GW, Burris JM, Burlew MM, Mandel JH. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med. 2003;45(3):260-70.
10. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med. 2006;48(8):759-70.
11. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115(11):1596-602.
12. Ishibashi H, Ishida H, Matsuoka M, Tominaga N, Arizono K. Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro. Biol Pharm Bull. 2007;30(7):1358-9.
13. Liu C, Du Y, Zhou B. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat Toxicol. 2007;85(4):267-77.
14. Wei Y, Dai J, Liu M, Wang J, Xu M, Zha J et al. Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ Toxicol Chem. 2007;26(11):2440-7.
15. Biegel LB, Liu RC, Hurtt ME, Cook JC. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol. 1995;134(1):18-25.
16. Shi Z, Zhang H, Liu Y, Xu M, Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol Sci. 2007;98(1):206-15.
17. Jensen AA, Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl. 2008;31 2: 161-9.
18. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ et al. Breastfeeding and the use of human milk. Pediatrics. 2005;115(2):496-506.
19. Forste R, Hoffmann JP. Are US mothers meeting the Healthy People 2010 breastfeeding targets for initiation, duration, and exclusivity? The 2003 and 2004 National Immunization Surveys. J Hum Lact. 2008;24(3):278-88.
20. Lee WT, Lui SS, Chan V, Wong E, Lau J. A population-based survey on infant feeding practice (0-2 years) in Hong Kong: breastfeeding rate and patterns among 3,161 infants below 6 months old. Asia Pac J Clin Nutr. 2006;15(3):377-87.
21. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM et al. The Danish National Birth Cohort - its background, structure and aim. Scand J Public Health. 2001;29(4):300-7.
22. Fei C, McLaughlin JK, Tarone RE, Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect. 2007;115(11):1677-82.
23. Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect. 2008;116(10):1391-5.
24. Ehresman DJ, Froehlich JW, Olsen GW, Chang SC, Butenhoff JL. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res. 2007;103(2):176-84.
25. WHO. Indicators for assessing breastfeeding practices. Geneva: WHO/CDD/SER/9114; 1991.
26. Baker JL, Michaelsen KF, Sorensen TI, Rasmussen KM. High prepregnant body mass index is associated with early termination of full and any breastfeeding in Danish women. Am J Clin Nutr. 2007;86(2):404-11.
27. Tao L, Kannan K, Wong CM, Arcaro KF, Butenhoff JL. Perfluorinated compounds in human milk from Massachusetts, U.S.A. Environ Sci Technol. 2008;42(8):3096-101.
28. Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect. 2003;111(16):1892-901.
29. Cupul-Uicab LA, Gladen BC, Hernandez-Avila M, Weber JP, Longnecker MP. DDE, a degradation product of DDT, and duration of lactation in a highly exposed area of Mexico. Environ Health Perspect. 2008;116(2):179-83.
30. Gladen BC, Rogan WJ. DDE and shortened duration of lactation in a northern Mexican town. Am J Public Health. 1995;85(4):504-8.
31. Vestermark V, Hogdall CK, Plenov G, Birch M, Toftager-Larsen K. The duration of breast-feeding. A longitudinal prospective study in Denmark. Scand J Soc Med. 1991;19(2):105-9.
32. Nagy E, Orvos H, Pal A, Kovacs L, Loveland K. Breastfeeding duration and previous breastfeeding experience. Acta Paediatr. 2001;90(1):51-6.
33. So MK, Yamashita N, Taniyasu S, Jiang Q, Giesy JP, Chen K et al. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol. 2006;40(9):2924-9.
34. Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect. 2007;115(2):226-30.
35. Volkel W, Genzel-Boroviczeny O, Demmelmair H, Gebauer C, Koletzko B, Twardella D et al. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int J Hyg Environ Health. 2008;211(3-4):440-6.
36. Zuppa A, Tornesello A, Papacci P, Tortorolo G, Segni G, Lafuenti G et al. Relationship between maternal parity, basal prolactin levels and neonatal breast milk intake. Biol Neonate. 1988;53(3):144-7.
37. Bystrova K, Widstrom AM, Matthiesen AS, Ransjo-Arvidson AB, Welles-Nystrom B, Vorontsov I et al. Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg. Int Breastfeed J. 2007 May 8;2:9.
38. Baxter J, Cooklin AR, Smith J. Which mothers wean their babies prematurely from full breastfeeding? An Australian cohort study. Acta Paediatr. 2009;98(8):1274-7.
39. Lande B, Andersen LF, Baerug A, Trygg KU, Lund-Larsen K, Veierod MB et al. Infant feeding practices and associated factors in the first six months of life: the Norwegian infant nutrition survey. Acta Paediatr. 2003;92(2):152-61.